Both in Biotechnology
Odyssey Therapeutics vs Monte Rosa Therapeutics
Over the past year ODTX returned −20.7% and GLUE returned −23.5%; their daily moves had a correlation of 0.53.
ODTX −20.7% GLUE −23.5%Growth of $1, one year, split-adjusted
| Metric | ODTX | GLUE |
|---|---|---|
| Price | $19.54 | $10.76 |
| Market cap | $939.1M | $918.0M |
| Today | −1.46% | −1.01% |
| 1 month | −4.3% | −4.4% |
| 6 months | — | −42.8% |
| Year to date | — | −31.4% |
| 1 year | — | −13.9% |
| Revenue growth (YoY) | — | −61.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −483.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 32.0× |
| Net cash | $310.6M | $621.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 52.5% |
| Short % of float | 13.6% | 41.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).